Functional Genomics & Multi-Omics

Spatial Multi-Omics Service for Animal Disease Models

Connect tissue morphology with spatial transcriptomics, protein-marker mapping, and region-aware bioinformatics. BioVenic supports animal disease model studies from specimen and assay planning through histological annotation, spatial pathway analysis, cross-sample comparison, and interpretable research reports.

Spatial context changes the biological question

Animal Disease Model Omics, Resolved in Tissue Space

Bulk expression profiles can obscure where cells and signaling programs reside. Spatial multi-omics brings transcript and protein information back to tissue architecture, helping investigators assess immune infiltration, lesion margins, stromal remodeling, and disease-associated niches without discarding regional context.

BioVenic offers project-tailored study design and analysis for veterinary and comparative animal research. We align experimental modality, tissue quality, annotation strategy, and cross-sample comparisons with the biological question, rather than treating every sample as a uniform field of measurement.

Service scope

Spatial Transcriptomics, Protein Mapping, and Histology Integration

Studies may involve transcriptome-scale spatial RNA profiling, region-selected gene panels, multiplex protein detection, and conventional tissue staining. Available combinations are determined during feasibility assessment; not every measurement is available on every animal species, preservation type, or instrument format.

01

Tissue and Assay Feasibility

Review species and genome annotation, sample allocation, FFPE or frozen status, RNA integrity, morphology, section thickness, area of interest, and replicate structure. Recommend a spatial-resolution and modality strategy suited to available specimens.

02

Spatial RNA Profiling

Plan whole-transcriptome or targeted spatial expression workflows where compatible, including capture-area selection, library or probe QC, reference alignment, spatial expression matrices, and preliminary region-specific gene analysis.

03

Spatial Protein and Marker Readouts

Select protein-marker panels or targeted staining to resolve immune, vascular, epithelial, and stromal compartments. Evaluate antibody species reactivity and appropriate control tissues; integrate multiplex imaging or IHC outputs when scientifically justified.

04

Pathology-Guided Region Annotation

Register assay images against histology, delineate lesions and adjacent tissue, capture region annotations, and compare cellular neighborhoods. Record registration confidence, segmentation criteria, and ambiguous boundaries for review.

An integrated research path

Our Spatial Multi-Omics Workflow

A connected workflow keeps tissue identity, assay QC, and analytical assumptions traceable from the first specimen to the final comparison.

01

Define the Study

Questions, controls, cohorts, tissue selection, modality choice, and pilot criteria.

02

Qualify Samples

Histology review, preservation QC, tissue mapping, and sample tracking.

03

Profile in Space

Spatial RNA and selected protein measurements with assay-specific quality metrics.

04

Integrate & Analyze

Align regions, annotate cell states, test spatial pathways, and compare groups.

05

Report & Review

Deliver interpretable maps, ranked signals, methods, limitations, and validation priorities.

Working with archival tissue or a non-model species?

A feasibility or small-scale pilot can test sample integrity, probe compatibility, and region detectability before larger cohorts are profiled.

From region to mechanism

Region-Aware Analysis for Animal Disease Models

Our analysis framework brings together spatial coordinates, tissue labels, molecular expression, and sample metadata. It supports hypothesis generation while separating exploratory cell-state inference from directly measured signals.

Where method resolution is limited, inferred cell types or interactions are reported as estimates requiring independent confirmation, not as direct single-cell measurements.
Research Question Analysis Approach Typical Output
Where do immune cells accumulate? Region-defined marker localization, spatial enrichment, immune neighborhood assessment Immune-compartment maps, infiltration contrasts, region summary statistics
What changes at lesion boundaries? Histology alignment, lesion–stroma interface annotation, spatially variable gene analysis Boundary overlays, differential region signatures, candidate transition markers
Which pathways define tissue remodeling? Pathway scoring, compartment-aware expression testing, targeted protein corroboration Region-specific pathway reports, effect estimates, prioritized hypotheses
Are patterns consistent across animals? Sample-level QC, biological replicate comparison, batch-effect assessment Cross-sample concordance, uncertainty summaries, group comparison figures

Immune Infiltration

Map lymphoid and myeloid signals around disease compartments, using target markers and controls appropriate to the study species.

Lesion and Interface Biology

Compare lesion centers, edges, and neighboring regions without conflating distinct histological states or sample orientations.

Cross-Sample Interpretation

Report group-level consistency, sample-specific departures, limitations in cell annotation, and actionable follow-up assay choices.

Documentation built for research teams

Spatial Omics Deliverables and Study Records

Outputs are defined at project kickoff and aligned with the selected assay, species reference resources, data-sharing requirements, and analysis complexity. Typical deliverables include:

  • Study design, specimen metadata, assay suitability review, and tissue region rationale.
  • Assay QC summaries, image alignment records, and pathologist-reviewed region annotations where scoped.
  • Spatial expression matrices or protein-marker measurements, with available raw files and analysis settings.
  • Annotated tissue maps, region contrasts, spatial enrichment results, and pathway interpretation.
  • Cross-animal comparisons, limitations, and prioritized biomarker or orthogonal-validation recommendations.

What to Share for Project Scoping

The most useful starting information is a clear biological contrast, not a preselected instrument.

Model and cohort
Species, strain/breed when relevant, disease model, biological replicates, and groups.
Specimens
Tissue site, storage, FFPE/frozen format, available sections or blocks, and histology.
Priority endpoints
Immune niches, lesion borders, remodeling pathways, or targets for confirmation.

Published Data on Spatial Protein Mapping in Canine Disease Models

In a 2026 Journal of Translational Medicine study, Beck and colleagues used six-marker multiplex fluorescence imaging to examine canine osteosarcoma metastasis in lung tissue. The published figure maps tumor-associated SATB2, vascular CD31, lung epithelial markers, T-cell CD3, and macrophage CD204 within the same tissue context, illustrating how spatial protein readouts can distinguish overlapping tumor and host compartments.

The study highlights why marker specificity, cross-species antibody validation, control tissues, and anatomical interpretation matter when building spatial assays. For animal disease model programs, these considerations inform the choice of spatial transcriptomics and proteomics workflows, pathology-guided region annotation, and orthogonal confirmation. The published images are independent literature examples, not BioVenic-generated study results.

Multiplex fluorescence spatial protein staining of canine osteosarcoma lung metastasis, showing tumor and immune cell markers within tissue architecture. (OA Literature)
Fig.1 Multiplex imaging of the canine osteosarcoma tumor microenvironment in lung tissue (reproduced without modification). 1,3

Our Advantages in Animal Spatial Omics Research

Designed around specimen reality, molecular evidence, and interpretable research questions.

Species-Aware Planning

Match assay requirements to tissue condition, reference annotations, and model-specific biology.

Integrated Tissue Context

Combine spatial expression and protein evidence with histological region interpretation.

Traceable Analysis

Document QC decisions, annotation choices, sample comparisons, and analytical limitations.

Validation-Oriented Reporting

Prioritize candidate mechanisms and practical follow-up measurements for experimental confirmation.

Frequently Asked Questions

Projects can be considered for companion animals, livestock, poultry, and research models, subject to assay availability and sample suitability. Please share species, tissue, disease model, preservation type, and section dimensions so platform and probe compatibility can be assessed before study design.

References

  1. Beck, Jessica A., et al. "Spatial resolution of the metastatic osteosarcoma tumor microenvironment using immunolabeling across murine, canine and human lung." Journal of Translational Medicine 24 (2026): 336. https://doi.org/10.1186/s12967-025-07367-5
  2. Weiderman, Rachael M., et al. "Applications of Spatial Transcriptomics in Veterinary Medicine: A Scoping Review of Research, Diagnostics, and Treatment Strategies." International Journal of Molecular Sciences 26.13 (2025): 6163. https://doi.org/10.3390/ijms26136163
  3. Distributed under Open Access license CC BY 4.0, without modification.
Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Inquiry Basket